Cefminox is a broad-spectrum, bactericidal cephalosporin antibiotic. It is especially effective against Gram-negative and anaerobic bacteria. [citation needed] The following represents MIC data for a few medically significant microorganisms. Clostridioides difficile: 2 - 4 μg/ml; Escherichia coli: 0.125 - 16 μg/ml; Pseudomonas aeruginosa: 256 ...

Cefminox (INN) is a second generation cephalosporin antibiotic. It is approved for use in Japan. The next evolution of DrugBank is here. Designed for scientists, driven by AI, and powered by real-time insights. This is drug intelligence, redefined. Build, train, & validate predictive machine-learning models with structured datasets.

Cefminox is a semisynthetic, second-generation, beta-lactamase-stable cephalosporin with antibacterial activity. Cefminox binds to and inactivates penicillin -binding proteins (PBPs) located on the inner membrane of the bacterial cell wall.

头孢米诺钠，是一种有机化合物，化学式为C16H20N7NaO7S3，主要用作β-内酰胺类抗生素，头抱菌素类。 用于 扁桃体 、 呼吸道 、 泌尿道 、胆道、腹腔、子宫等部位感染，也可用于败血症。 头孢米诺钠临床应用于 敏感菌 所致的下列感染： 1、 呼吸道感染。 2、 泌尿道感染。 3、腹内感染（包括 胆道感染 、腹膜炎等）。 4、泌尿、 生殖系统 感染。 5、败血症。 1、头孢米诺钠 不良反应 发生率 为2.11%。 主要不良反应有： （1）用药后可见食欲不振、恶心、呕吐、腹泻等 …

Cefminox is a new cephamycin antibiotic possessing a D-amino acid moiety derived from D-cysteine at the C-7B side chain. Cefminox is active against a wide range of bacteria, especially Gram-negative and anaerobic bacteria. Cefminox shows excellent in vivo efficacy (ED50) which is higher than would b …

Cefminox is a broad-spectrum, bactericidal cephalosporin antibiotic. It is especially effective against Gram-negative and anaerobic bacteria. It is indicated in treatment of the following infections caused by sensitive bacteria: 1.

Cefminox is a semisynthetic, second-generation, beta-lactamase-stable cephalosporin with antibacterial activity. Cefminox binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall.

Cefminox sodium (MT-141) is a semisynthetic cephamycin, which exhibits a broad spectrum of antibacterial activity. Cefminox sodium (MT-141) also acts as a dual agonist of prostacyclin receptor (IP) and PPARγ, upregulates cAMP production and PTEN expression and inhibits Akt/mTOR signaling.

医药魔方NextPharma®全球新药数据库为您提供「头孢米诺」药品的基本信息（药品名称、药品类别、靶点、作用机制、药品简介、研发机构、最高研发阶段、审评审批类型、外置链接）。 了解更多药品相关信息，欢迎申请试用企业版。

英文名称：Cefminox Sodium for Injection 汉语拼音：Zhusheyong Toubaominuona 【成份】本品主要成份为头孢米诺钠。 【性状】本品为白色至微黄色结晶性粉末。 【适应症】 本品可用于治疗上述敏感细菌引起的下列感染症：